Genomics Law Report's Dan Vorhaus questions the distinctions in the FDA's policy on direct-to-consumer genetic testing kits. In a comment to the New York Times, Vorhaus says, the FDA seems to be singling out over-the-counter tests for regulatory review. But, Vorhaus asks, is point of sale really an appropriate distinction to make?

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.